EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Ladybug Resource Group Inc (LBRG) fair value: what the stock is really worth

As of Sep 25, 2026: fair value of Ladybug Resource Group Inc $0.00, price $0.00, upside -3.3%, quality 54 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · US · ISIN US50582Q2021

LR Ladybug Resource Group Inc logo Thin data Sep 23, 2026

Ladybug Resource Group Inc

LBRG · US

NeutralThe stock looks roughly fairly valued with average quality.

·Fair value $0.0029 · Fairly valued (−3%)
!Quality 54/100
!Mixed Growth
!Loss-making · -1.7% net margin (FY2024)
!Negative equity (buybacks among others) · negative free cash flow
!Trails peers (1/5)
!Narrow moat 23/100
!Evidence only low, so the estimate is less certain
!Weak on valuation: 29 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$0.0900 $0.0001 Fair Value $0.0029 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range $0.0001 – $0.0900 · the $0.0030 price screens above the $0.0029 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.

Follow Ladybug Resource Group in your weekly email

Every Wednesday you see whether Ladybug Resource Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Ladybug Resource Group, Inc. designs the message or marketing theme included on Internet Websites, primarily focusing on the Websites of the funeral industry in the Seattle, Washington area.

Show more

Ladybug Resource Group, Inc. designs the message or marketing theme included on Internet Websites, primarily focusing on the Websites of the funeral industry in the Seattle, Washington area. The company is also developing Solar Tracer, a solar collector that would use concentrating solar power technology to capture energy from the sun and transfer it in the form of heat to run steam turbine generators. In addition, it offers health supplements for men and women that help with issues, such as sleeplessness, headaches, aches and pains, mood improvement, energy, calm support, and appetite control; athletic supplements to enhance and sustain athletic performance; and nutritional supplement products. The company intends to sell its health products and formulas through wholesale channels; or license products to other manufacturers or multi-level marketing organizations. Ladybug Resource Group was founded in 2007 and is based in Kirkland, Washington.

Stock analysis

Ladybug Resource Group Inc (LBRG) currently trades at $0.0030, while our model-based Fair Value estimate is $0.0029, implying the stock looks roughly 3.4% fairly valued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $0.0200 per share, and 5 of the 5 models we run sit above the $0.0030 price.

Bear case: the Earnings-Based group reads lowest at $0.0100, and 0 of the 5 models stay below the price. Evidence for this calculation is low.

Quality & growth

The Quality Score stands at 54/100 (solid quality), in the Healthcare sector.

Mixed Growth: Spin-off in 2024: revenue and profit before it include the divested business. Growth is measured afresh from 2024.

Ladybug Resource Group Inc reported revenue of $1.2M in FY2024 versus $41.6K in FY2014, a compound +39.9%/yr. Reported net income was −$20.5K in FY2024.

Key figures

Market cap $2.0M · Net margin −1.7% · Return on assets (EBIT) −33.0% · Operating margin −351% · Free cash flow −$116K · Net cash $387.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (medium confidence).

What moves the price

The share trades about 80% below its 52-week high and 25% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 10% fair-value upside, at −3%, LBRG screens richer than that median.

Fair Value models

Bear $0.0029 Fair Value $0.0029 Bull $0.0029
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
EPV $0.0100 $0.0100 $0.0100 74
ROIC Compounder $0.0100 $0.0100 $0.0100 70
EV/EBITDA $0.0100 $0.0200 $0.0200 67
All 5 models by family
Earnings-Based
EPV $0.0100 $0.0100 $0.0100 74
Multiples
EV/EBIT $0.0200 $0.0200 $0.0300 66
EV/EBITDA $0.0100 $0.0200 $0.0200 67
EV/Revenue n/a $0.0100 $0.0100 51
Economic Profit
ROIC Compounder $0.0100 $0.0100 $0.0100 70

Open the full fair value analysis →

Notify me when LBRG reaches fair value

Put LBRG on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 54/100

Of which business quality 54 · Market factors (momentum, volatility) 15

Profitability 51
Margins and returns on capital today
Quality Growth 40
Are margins and returns improving?
Cashflow 33
Earnings quality: real cash, not paper profit
Fin. Strength 50
Balance sheet, leverage, solvency risk
Investment 67
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 0
Price trend over the last 3–12 months (market factor)
52W Momentum 2
Distance to the 52-week high (market factor)
Net Issuance 100
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 55/100
Spin-off in 2024: revenue and profit before it include the divested business. Growth is measured afresh from 2024.
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−78.9% (2007) → 33.6% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2024 is a loss year, no rate is defined from a loss
not computed

Watch LBRG, get fair value alerts →

Compare Ladybug Resource Group Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceutical Retailers · 61 stocks

Beats the industry median on 1/5 measures
Overall it trails its industry peers.
Valuation
Quality Score 52 · Above median
Fair Value upside −3% · Below median
Profitability
Return on equity (TTM) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets −89% · Bottom 25%
Net margin (TTM) −2% · Bottom 25%
Growth and dividend
Revenue growth 0% · Below median
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Pharmaceutical Retailers median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)29 · sector 33
FUTURE (revenue growth)0 · sector 17
PAST (return on equity)0 · sector 22
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 66

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Alibaba Health Information Technology Limited 0241 HK$2.84 HK$2.03 −28%
Yifeng Pharmacy Chain Co 603939 ¥22.09 ¥40.59 +84%
DaShenLin Pharmaceutical Group 603233 ¥17.97 ¥26.45 +47%
LBX Pharmacy Chain Joint Stock Company 603883 ¥12.90 ¥14.19 +10%
MedPlus Health Services Limited MEDPLUS ₹662.00 ₹393.38 −41%
Yixintang Pharmaceutical Group 002727 ¥10.96 ¥9.51 −13%
Anhui Huaren Health Pharmaceutical Co 301408 ¥15.56 ¥17.12 +10%
ShuYu Civilian Pharmacy Corp 301017 ¥12.95 ¥5.91 −54%
Apotea AB APOTEA kr 81.90 kr 46.46 −43%
Luyan Pharma Co 002788 ¥11.24 ¥15.91 +42%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Ladybug Resource Group Inc Fair Value". https://www.fairvalue-calculator.com/stock/LBRG

Frequently asked questions

Is Ladybug Resource Group Inc (LBRG) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $0.0029 versus a price of $0.0030, about −3% upside (fairly valued).
What is the fair value of LBRG?
Our model-based fair value for Ladybug Resource Group Inc is $0.0029 (as of Sep 23, 2026), built from audited fundamentals. The current price: $0.0030.
What is the quality score of LBRG?
Ladybug Resource Group Inc has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Ladybug Resource Group Inc (LBRG)?
Our model-based price target is the fair value of $0.0029 (as of Sep 23, 2026) from 5 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Ladybug Resource Group Inc stock forecast for 2026?
Our models put fair value at $0.0029, about −3% upside versus a price of $0.0030 (fairly valued). The calculation is refreshed regularly with new filings.
What is the intrinsic value of Ladybug Resource Group Inc (LBRG)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Ladybug Resource Group Inc it is $0.0029 per share (as of Sep 23, 2026), against a price of $0.0030. It is the blended result of 5 valuation models (cash flow, earnings, asset, dividend).
Is Ladybug Resource Group Inc stock overvalued or undervalued in 2026?
As of Sep 23, 2026, LBRG trades above its calculated fair value: price $0.0030, fair value $0.0029, a gap of about −3% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of LBRG?
No. The price is what the market pays today ($0.0030); the fair value is what the company's own numbers justify ($0.0029). For Ladybug Resource Group Inc the two are $0.0001 per share apart. That gap is exactly why we show both numbers side by side.
How much is Ladybug Resource Group Inc worth?
The market values Ladybug Resource Group Inc at about $2.0M (market capitalisation, as of Sep 23, 2026). Per share that is $0.0030; our models calculate a fair value of $0.0029 per share.
How solid is the balance sheet of Ladybug Resource Group Inc (LBRG)?
Balance-sheet figures for Ladybug Resource Group Inc (as of Sep 23, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is LBRG from its 52-week high?
Ladybug Resource Group Inc trades at $0.0030, about 80% below its 52-week high of $0.0152 and 25% above the low of $0.0024 (as of Sep 25, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0029 is for.
Which stocks are comparable to Ladybug Resource Group Inc?
From the same area (Healthcare) we also value Alibaba Health Information Technology Limited, Yifeng Pharmacy Chain Co, DaShenLin Pharmaceutical Group, LBX Pharmacy Chain Joint Stock Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Ladybug Resource Group Inc stock attractive at the current price?
The data as of Sep 23, 2026: price $0.0030, calculated fair value $0.0029 (−3%), Quality Score 54/100, from 5 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of LBRG calculated?
We run Ladybug Resource Group Inc through 5 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0029, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. Ladybug Resource Group Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Ladybug Resource Group Inc (LBRG)?
The closing price on Sep 25, 2026 was $0.0030. Our model-based fair value is $0.0029, about −3% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Ladybug Resource Group Inc right now?
The price sits above even our optimistic bull case ($0.0029). The favourable scenario is already priced in. The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Ladybug Resource Group Inc

How large is the market capitalisation of Ladybug Resource Group Inc (LBRG)?
The market capitalisation of Ladybug Resource Group Inc is $2.0M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the net margin of Ladybug Resource Group Inc (LBRG)?
The net margin of Ladybug Resource Group Inc is −1.7% (fiscal year 2024). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Ladybug Resource Group Inc (LBRG)?
On an EBIT basis the return on assets of Ladybug Resource Group Inc is −33.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Ladybug Resource Group Inc (LBRG)?
The operating margin of Ladybug Resource Group Inc is −351% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How much free cash flow does Ladybug Resource Group Inc (LBRG) generate?
The free cash flow of Ladybug Resource Group Inc is −$116K (fiscal year 2022). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Ladybug Resource Group Inc (LBRG) hold?
Ladybug Resource Group Inc holds more cash than debt, $387 net (fiscal year 2024). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Ladybug Resource Group Inc in the live analysis

One click puts Ladybug Resource Group Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.